The University of North Florida Materials Science and Engineering Research Facility (MSERF) has partnered with TESCAN, a leading manufacturer of electron and light microscopes, in the installation of one of its new Q-Phase microscopes, a unique instrument for quantitative phase imaging based on holographic microscopy.
The Q-Phase microscope is a one-of-a-kind holographic microscope capable of imaging live cells for up to five days. Traditional light microscopy of cells requires staining and chemical treatments that capture the state of the cell in time but kills the cell in the process. This new technology allows cells to be imaged while living over the course of days.
“The partnership with TESCAN affords the University the ability to gather cutting-edge data from the latest high-tech equipment” said Dr. Paul Eason, UNF-MSERF director and associate professor of mechanical engineering in the College of Computing, Engineering and Construction.
The agreement between the University and TESCAN provides UNF the opportunity to house brand new and unique microscopes for the purpose of instrument validation and demonstration for potential users. The Q-Phase microscope, housed at MSERF in the newly renovated Skinner-Jones Hall, is on the UNF campus for a 90-day trial installation.
Researchers both at UNF and the Mayo Clinic are taking advantage of the trial installation and utilizing the high-powered device in their respective studies of treating various types of cancer.
Image Credit: AZO Nano
News This Week
If a little humanoid robot begged you to not shut it off, would you show compassion? In an experiment designed to investigate how people treat robots when they act like humans, many participants struggled [...]
Artificial intelligence and machine learning tools have the potential to analyze large datasets and extract meaningful insights to enhance patient outcomes, an ability that is proving helpful in radiology and pathology. Images obtained by [...]
Researchers at the University of East Anglia have developed a new nanoparticle-based cancer therapy to deliver a combination therapy directly to cancer cells. The new therapy, which has been demonstrated to make prostate cancer [...]
When Joe Rubinsztain started gMed, he was admittedly young—only a few years removed from medical school— and he just didn’t understand leadership that well. “I needed to be abreast of everything and understand everything [...]
Healthcare organizations are likely to see a rapidly growing market around artificial intelligence tools for medical imaging, a new report predicts. The market for artificial intelligence (AI) tools to process and analyze medical imaging [...]
Tuberculosis, a bacterial disease which predominantly affects the lungs, isn’t all that common a sight in the United States. On average, fewer than 10,000 cases are reported each year in a country with [...]
Implantation of a stent-like flow diverter can offer one option for less invasive treatment of brain aneurysms – bulges in blood vessels – but the procedure requires frequent monitoring while the vessels heal. Now, [...]
Clinicians have often pondered if cancer cells could be selectively targeted, and how payloads ranging from fluorescent dyes to oncology drugs could be accurately delivered to these cells, and then safely cleared through the [...]